Aberrant Glycosylation in Pancreatic Ductal Adenocarcinoma 3D Organoids Is Mediated by KRAS Mutations

<div>KRAS mutation profile of the organoids. (a) Red areas in the left chart indicate KRAS -positive while blue indicates KRAS wild -type. (b) Brightfield images, H&amp;E staining and CK19 immunostaining of 2 organoids cultures are shown (left: KRAS wild -type organoid, right: KRAS mutant organoid). Scale bar: 50 <i>μ</i>m.</div>

Journal of Oncology

fig2

Figure 2

Figure 2: Aberrant Glycosylation in Pancreatic Ductal Adenocarcinoma 3D Organoids Is Mediated by KRAS Mutations 